Adventris Pharmaceuticals (Winter 2023) - Startups.RIP

Back to all companies

Adventris Pharmaceuticals (Winter 2023) - Startups.RIP

Back to all companies

Adventris Pharmaceuticals

Winter 2023Active

Adventris makes cancer vaccines. Our platform solves the problem of targeting poorly immunogenic oncogenes. Our first "off-the-shelf" vaccine targets KRAS, the most common cancer oncogene. In the long run, we envision a world where every adult receives our pan-cancer vaccines annually – preventing the majority of cancer deaths. If you are interested in learning more about our approach to treat and prevent cancer, please reach out to us at contact@adventris.com

Founded

Unknown

Category

Biotech

YC Company Page adventris.com

No report yet — want us to research it?

This company has not been analyzed yet. Request a research report and we will email you when it is ready to view.

We will notify you as soon as the analysis is complete.